Copyright: ©Author(s) 2026.
World J Clin Cases. Apr 6, 2026; 14(10): 118053
Published online Apr 6, 2026. doi: 10.12998/wjcc.v14.i10.118053
Published online Apr 6, 2026. doi: 10.12998/wjcc.v14.i10.118053
Table 1 Baseline characteristics of the participants, n (%)/mean ± SD
| Baseline characteristics | |
| Age | 7.15 ± 0.67 |
| Gender | Males: 12 (60) |
| Females: 8 (40) | |
| Weight | 25.4 ± 1.47 |
| Frankl behaviour rating-visit 1 | Positive: 6 (44) |
| Definitely positive: 14 (56) | |
| Frankl behaviour rating-visit 2 | Positive: 9 (45) |
| Definitely positive: 11 (55) | |
Table 2 Pain experienced during injection with 4% articaine and 2% lignocaine according to the Wong-Baker Faces Pain Rating Scale, n (%)
| Item | No hurt (0) | Little bit (2) | Little more (4) | Even more (6) | Whole lot (8) | Hurt worst (10) | Median (interquartile range) | P value |
| Articaine | 3 (15.0) | 8 (40.0) | 5 (25.0) | 3 (15.0) | 1 (5.0) | 0 (0.0) | 2 (2, 4) | 0.16 |
| Lignocaine | 7 (35.0) | 7 (35.0) | 4 (20.0) | 1 (5.0) | 1 (5.0) | 0 (0.0) | 2 (0, 4) |
Table 3 Pain experienced during injection with 4% articaine and 2% lignocaine according to the Face, Legs, Activity, Cry, and Consolability scale, n (%)
| Item | Relaxed (1) | Mild (2) | Moderate (3) | Severe (4) | Median (interquartile range) | P value |
| Articaine | 8 (40.0) | 8 (40.0) | 3 (15.0) | 1 (5.0) | 2 (1, 2) | 0.856 |
| Lignocaine | 7 (35.0) | 8 (40.0) | 5 (25.0) | 0 (0.0) | 2 (1, 2) |
Table 4 Pain experienced during access cavity preparation with 4% articaine and 2% lignocaine according to the Wong-Baker Faces Pain Rating Scale, n (%)
| Item | No hurt (0) | Little bit (2) | Little more (4) | Even more (6) | Whole lot (8) | Hurt worst (10) | Median (interquartile range) | P value |
| Articaine | 10 (50.0) | 9 (45.0) | 1 (5.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0, 2) | 0.043a |
| Lignocaine | 5 (25.0) | 9 (45.0) | 2 (10.0) | 3 (15.0) | 1 (5.0) | 0 (0.0) | 2 (0, 4) |
Table 5 Pain experienced during access cavity preparation with 4% articaine and 2% lignocaine according to the Face, Legs, Activity, Cry, and Consolability scale, n (%)
| Item | Relaxed (1) | Mild (2) | Moderate (3) | Severe (4) | Median (interquartile range) | P value |
| Articaine | 14 (70.0) | 5 (25.0) | 1 (5.0) | 0 (0.0) | 1 (1, 2) | 0.010a |
| Lignocaine | 5 (25.0) | 9 (45.0) | 2 (10.0) | 4 (20.0) | 2 (1, 3) |
Table 6 Pain experienced during canal instrumentation with 4% articaine and 2% lignocaine according to the Wong-Baker Faces Pain Rating Scale, n (%)
| Item | No hurt (0) | Little bit (2) | Little more (4) | Even more (6) | Whole lot (8) | Hurt worst (10) | Median (interquartile range) | P value |
| Articaine | 15 (75.0) | 5 (25.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0, 0) | 0.132 |
| Lignocaine | 10 (50.0) | 5 (25.0) | 1 (5.0) | 0 (0.0) | 0 (0.0) | 4 (20.0) | 0 (0, 10) |
Table 7 Pain experienced during canal instrumentation with 4% articaine and 2% lignocaine according to the Face, Legs, Activity, Cry, and Consolability scale, n (%)
| Item | Relaxed (1) | Mild (2) | Moderate (3) | Severe (4) | Median (interquartile range) | P value |
| Articaine | 17 (85.0) | 3 (15.0) | 0 (0.0) | 0 (0.0) | 1 (1, 1) | 0.032a |
| Lignocaine | 12 (60.0) | 3 (15.0) | 1 (5.0) | 4 (20.0) | 1 (1, 2) |
- Citation: D’Souza OK. Comparative evaluation of anesthetic efficacy of articaine vs lignocaine during root canal therapy in hypomineralized second primary molars. World J Clin Cases 2026; 14(10): 118053
- URL: https://www.wjgnet.com/2307-8960/full/v14/i10/118053.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i10.118053
